DS Biopharma to Present at UBS Global Healthcare Conference

DUBLIN, May 14, 2015 /PRNewswire/ --

DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present at the UBS Global Healthcare Conference in New York on Monday May 18.

Dr. John Climax, Chairman and CEO of DS will present at 10am (EDT) in the Sheraton New York Hotel, 811 Seventh Avenue, New York.

"We look forward to presenting DS Biopharma and our proprietary lipid technology development pipeline at the UBS Global Healthcare Conference. The Company's bioactive lipids look to address unmet needs in atopic dermatitis, liver fibrosis and non-alcoholic steatohepatitis (NASH)," commented Dr. Climax.

About DS Biopharma  

DS Biopharma, headquartered in Dublin, Ireland, is a privately held drug discovery and development company working on new medicines that improve the quality of life for people with diseases for which existing therapies are ineffective or unsafe. DS has developed a proprietary bioactive lipid technology platform from which it is working on new approaches to treat non-alcoholic steatohepatitis (NASH), atopic dermatitis and other inflammatory and pulmonary disorders.

For more information, visit http://www.dsbiopharma.com

SOURCE DS Biopharma